Skip to main navigation Skip to search Skip to main content

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalLeukemia and Lymphoma
DOIs
StateAccepted/In press - 2026

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this